On April 25, 2018, Lifetech was included in the ranking of the "the Most Attentive List Company by Institution Investors of Shenzhen-Hongkong Stock Connect "
On April 19, 2018, Lifetech (1302.HK) was awarded as "listed company with the Best Medical Devies and Diagnosis "
LifeTech Scientific Corporation has entered into a strategic partnership with Ally Bridge Group (“ABG”).
Lifetech Scientific (Shenzhen) Co. Ltd is pleased to announce that its HeartTone™ implantable cardiac pacemaker has been approved by the China Food and Drug Administration (CFDA).
IrisFITTM PFO occluder, a proprietary and innovative product of LifeTech Scientific Corporation, enter the CFDA special fast track approval process for innovative medical devices.
LifeTech HeartToneTM pacemakers enter the CFDA special fast track approval process for innovative medical devices, known as “green channel”.
LifeTech (1302.HK) received CE Mark approval for its LAmbreTM left atrial appendage (LAA) closure system , on 15 June 2016. This is the first CE marked LAA closure system from China.
FemFlowTM DEB independently developed by LifeTech Scientific (Shenzhen) has formally passed the special review application of CFDA creative medical devices.
On Aug. 20th, 2015, the HeartR ASD/PDA/VSD Occluder manufactured by Lifetech got approval in Taiwan, which means these products can be advanced into Taiwan.
On Jane 22th, 2015, SeQure™ snare system of Lifetech got local approval in Brazil, the product is allowed to be sold in Brazil.